A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease-Reference-Cited by-同舟云学术

A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease

Published:2022-12 Issue:5 Volume:114 Page:883-891
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kim Jina,Chang Jee Suk^ORCID,Sung Wonmo,Kim Jin Sung,Kim Tae Hyung,Choi Seo Hee,Kim Kyung Hwan,Ko Heejoo,Lee Hye Sun,Jeon Soyoung,Shin Sang Joon,Liu Mitchell,Olson Robert

Funder

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Oligometastasis: Past, present, future;Gutiontov;Int J Radiat Oncol Biol Phys,2020

2. Harrow S, Palma DA, Olson R, et al. Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET)–extended long-term outcomes [e-pub ahead of print]. Int J Radiat Oncol Biol Phys. doi: https://doi.org/10.1016/j.ijrobp.2022.05.004, accessed September 9, 2022.

3. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis;Pitroda;Nat Commun,2018